MICHAELA DEAN: Open Payments
NPI 1225711856 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 39 payments from 27 companies in 2025. Trend: 2023 $88 · 2024 $481 · 2025 $941
Food & beverage: $751Education: $190
| Company | Payments | Amount |
|---|---|---|
| SEAGEN INC. | 1 | $100 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| Novartis Pharmaceuticals Corporation | 2 | $81 |
| Janssen Biotech, Inc. | 3 | $74 |
| BeOne Medicines USA, Inc. | 4 | $72 |
| SERVIER PHARMACEUTICALS LLC | 3 | $66 |
| Daiichi Sankyo Inc. | 3 | $55 |
| Genentech USA, Inc. | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Astellas Pharma US Inc | 1 | $30 |
Products named: SARCLISA, KISQALI, TEVIMBRA, RYBREVANT, Enhertu, KEYTRUDA, CARVYKTI, Vyloy.
Industry payments across NE — which companies pay providers there.
